The hope of course is for the elusive announcement for a partnership of sorts with some upfront payment & milestones that could eventually lead into M&A activity. Even if it was for a certain region not worldwide would kick things off & bring in cash, but there will need to be a cash injection down the line if we want to progress the drug to gain the required data (in patients too!) that BP & FDA need to see.
Ball is in management's court and while we are a long way from the under the radar given our trip to USA, collaborations with KOLs, City of Hope (friendship restored!) & our partnerships with universities surely we have discussions ongoing in the background. DXB just had an upfront $10m payment hit the bank today with up to $200m or so plus royalties so imagine what Bisantrene upfront & milestones could be given the triangle report on valuation for multiple shots on goal.
Don't forget the FTO opportunity ahead https://www.cell.com/cancer-cell/pdfExtended/S1535-6108(20)30216-6
Sorry for rushed post.
Ann: Trading Halt, page-49
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.170(11.5%) |
Mkt cap ! $279.8M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.65 | $1.46 | $479.4K | 307.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 950 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 11353 | 4 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.63 |
Change
0.170 ( 10.6 %) |
||||
| Open | High | Low | Volume | ||
| $1.48 | $1.65 | $1.46 | 54704 | ||
| Last updated 15.57pm 03/06/2024 ? | |||||
| RAC (ASX) Chart |